- Home
- SPPL vs BFRI Comparison
SPPL vs BFRI Comparison
Compare SPPL & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPPL
- BFRI
- Stock Information
- Founded
- SPPL 2016
- BFRI 1997
- Country
- SPPL Singapore
- BFRI United States
- Employees
- SPPL N/A
- BFRI N/A
- Industry
- SPPL
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- SPPL
- BFRI Health Care
- Exchange
- SPPL Nasdaq
- BFRI Nasdaq
- Market Cap
- SPPL 9.8M
- BFRI 7.9M
- IPO Year
- SPPL 2023
- BFRI 2021
- Fundamental
- Price
- SPPL $3.50
- BFRI $1.06
- Analyst Decision
- SPPL
- BFRI Strong Buy
- Analyst Count
- SPPL 0
- BFRI 1
- Target Price
- SPPL N/A
- BFRI $2.75
- AVG Volume (30 Days)
- SPPL 43.2K
- BFRI 234.4K
- Earning Date
- SPPL 01-01-0001
- BFRI 08-13-2025
- Dividend Yield
- SPPL N/A
- BFRI N/A
- EPS Growth
- SPPL N/A
- BFRI N/A
- EPS
- SPPL N/A
- BFRI N/A
- Revenue
- SPPL $2,764,846.00
- BFRI $37,997,000.00
- Revenue This Year
- SPPL N/A
- BFRI $11.75
- Revenue Next Year
- SPPL N/A
- BFRI $17.09
- P/E Ratio
- SPPL N/A
- BFRI N/A
- Revenue Growth
- SPPL N/A
- BFRI 14.28
- 52 Week Low
- SPPL $2.02
- BFRI $0.54
- 52 Week High
- SPPL $16.80
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- SPPL 60.28
- BFRI 74.96
- Support Level
- SPPL $3.01
- BFRI $0.79
- Resistance Level
- SPPL $3.45
- BFRI $1.17
- Average True Range (ATR)
- SPPL 0.34
- BFRI 0.10
- MACD
- SPPL 0.03
- BFRI 0.03
- Stochastic Oscillator
- SPPL 56.60
- BFRI 77.91
About SPPL SIMPPLE LTD.
Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.